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Psoriasis is a common autoimmune skin condition affecting 2-4% of the worldwide
. po~ulation. It is common practice for nurses who do not specialize in the field of
:dermatology taking care of patients with psoriasis as primary or secondary condition.
"'fhi,s guide serves as a helpful tool for nurses. It provides information regarding psoriasis'
·;+physiological features, risk factors, treatment, and expected adverse effects.
··Psychological aspect of living with psoriasis on a day-to-day basis and effect it can have
on qualityof life are also addressed. Lastly, additional resources.are<listed for nurses'
andpatients' use.

By Elena Segev, BA

Sandra Restaino, DNP, FAANP
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Introduction to Psoriasis
Psoriasis is one of the most common autoimmune chronic conditions with 24% of worldwide population suffering from it. It is typical to all ethnicities,
races, ages, and sexes.
It is caused by abnormally fast skin cells proliferation which is mediated by
extremely reactive T-helper 17 (Th17) white blood cells and probably
related to angiogenesis (new blood vessels formation). It is believed to have
genetic predisposition. 49% of the patients have first degree relatives with
the disease. As much as 75% prevalence has been found in monozygotic
twins. A dominant allele is the related genetic component. Different
ethnicities have different gene for psoriasis singled out.

The exact trigger for psoriasis is unknown but it is associated with extreme
stress, alcohol consumption, certain diseases (streptococcal infections,
Crohn's disease), metabolic syndrome, and some medications.
This is a lifelong condition with no cure and is a truly human disease that is
not found in animals. This is why psoriasis is hard to mimic on laboratory
animals, which make a research more complicated. Symptom management is
the only current option for patients with psoriasis.
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Pathophysiology
Psoriasis is a chain ofhyperimmune reactions. Leukocytes Langerhans cells and
Thl7 cells release inflammatory cytokines as a reaction to a certain trigger.
Angiogenesis seems to promote those inflammatory reactions but also
streptococcal bacteria and physical damage. Inflammatory agents like tumor
necrosis factor (TNF-a), interleukins (IL) IL-23, IL-17, and interferon- y lead to
continuous over-reaction that causes an uncontrollable keratinocyte proliferation.
The usual cell's lifecycle of28 days shortens instead to four days.
It is diagnosed based on the gross features and family history of psoriasis. One of
the most common tools used to assess severity of the disorder is Psoriasis Area and
Severity Index (PASI) with rating 0 to 4, four being the most severe. Helpful links
are cited in the resources section.

Psoriasis is known to have a few related comorbidities. It includes psoriatic
arthritis, cardiovascular diseases, diabetes, skin infections, and various
psychological problems from distorted body image to depression.

Th17/ymphocytes and psoriasis: Th17 interact with immune cells, primarily dendritic cells
and fibroblasts residing in skin that trigger psoriatic reaction of keratinocytes (KS)
proliferation.
Image from JOurnal of Investigative Dermatology
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Types of Psoriasis
Plaque psoriasis
Most common type of psoriasis with distinguished
gross features. The most studied form.

Guttate psoriasis
Typical in children, onset usually indicates plaque
psoriasis in adulthood.
Pustular psoriasi!'

Relatively rare psoriasis.Generalized pustular
psoriasis: rapid spread of inflamed skin patches,
s· .
.
accompanied whhpain,Jever, and
I lymphadenopathy; Potentially life threatening du~ .to
its_d.e.manding effect onthe.cardio"vascular and
·
I. unnary systems.
.;

Erythmdermic psoriasis

Rare form of psoriasis. Erythema with severe

I itching, pain, and scaling. Weakened immune
system makes a patient vulnerable toinfections,
compromised body temperature homeostasis, and
chemical balance disruption.

Other forms of psoriasis
<~~

Inverse psoriasis (in skin folds)
<~~ Palmar (hand) psoriasis
• .Plantar (foot) psoriasis
<~> Nailfold.psoriasis.
<~> · Facial psoriasis
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Comorbidities
Patients with psoriasis are more likely to have or develop additional health conditions. Such
conditions include but not limited to:

Psoriatic arthritis: About 10% of psoriasis patients develop arthritis related to psoriatic
inflarmnatory reactions. This problem is especially overlooked in children if not reported.
Assess your patient for acute or chronic joint pain.

Cardiovascular diseases aud conditions: In recent years psoriasis is ·seen by the
specialists as an independent risk factor for developing cardiac conditions as myocardial
infarction and stroke and vascular diseases like peripheral vessels blood flow resistance,
cerebrovascular damage, and occlusive vascular disorders. Pay very close attention to the
patient's cardiovascular status. Blood pressure screening and cardiac function assessment
should be a priority.

Crohn's disease: Many researchers see a connection between both disorders. There is
strong evidence that the same gene is responsible for both. Assess for gastrointestinal tract
function, quality of stool, bowel movement, pain, and other signs and symptoms related to
Crohn 's disease.

Diabetes mellitus: Although there is no strong support that psoriasis causes DM, many
studies show that patients with psoriasis in general have higher rates of DM than general
population. Blood glucose and symptoms of diabetes should be a routine during annual
physical checkup for early detection.

Depression: Burden of a deforming disease can take toll on the mental status of the patient
with psoriasis. Do not forget to ask questions related to quality of life, mood, and selfimage. Prevention and treatment of depression is a very important step in successful
disease management.
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Treatment of Psoriasis
Traditional Methods

Treatment

Description

Considerations

Corticosteroids/
Retinoids/
Vitamin D analogs
Topical Agents

Steroid induced ointment,
first line treatment for newly
diagnosed and mild cases of
psoriasis by weakening
immune reaction and slowing
down cells growth.,.

Due to tissue thinning effect cannot be
used for long periods of time. Apply
carefully within a lesion border to
avoid healthy cells destruction.
Limited to mild and moderate cases.
Retinoid. and Vitamin D can be
teratogenic.

Phototherapy

Ultraviolet light B (UVB) and Performed in clinical setting. May
alleviate symptoms (itching, redness)
Psoralen Ultraviolet A
before clearing begins.
(PUVA). Penetrates skin,
A few studies warn about potential for
slows down keratinocytes
skin cancer. Urge patients to follow up
growth, and eradicates old
with dermatologist after treatment
tissue. One of the most
PUVA is considered a higher risk for
effective symptom
skin cancer developinent.
management.
Same mode of action as UVB
only from the sun. Some
geographical points of earth
present perfect conditions for
safe UVB penetration. Those
poits are the Dead Sea,
Balneo, Italy, many points in
Poland and more.

Systemic Agents

Systemic drugsthat act on .
immune system. Include
methotrexate (Trexall),
cyclosporine (Restasis), oral
retinoids.

6

In general any sun exposure of psoriatic
skin is beneficial.
Avoid overexposure. Recommend
gradual increase exposure time. Consult
doctor about plarming. Results might
not be inm1ediate; 2-4 weeks may be
needed before the improvement.

·Immunosuppressant. Watch for
opportunistic infections. Supplement
diet with folate .. Extremely teratogenic.

'Biologic Agents· ·

For treatment of moderate to
severe psoriasis. Monoclonal
antibodies suppress immune
reaction reversing psoriasis
symptoms. Includes brands
adalimumab (Humira),
etanercept (Enbrel),

Systemic immtmosuppressive. Pay
close attention to infections. Educate
about immunosuppression precautions
such as avoiding crowded places,
immunization, hand hygiene,
immediate attention from the healthcare
professional if infection signs occur

:;:m"h (Rcmi"<!o), ~.d
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Experimental Methods

;;'Treatment

Description

'+

Genetic Therapy

RroteinTherapy

Considerations

Certain foods are found to improve
,symptoms or to alleviate. thern.
{Favorable groups incl:ude fish, •
" ;Iamb, fruits, vegetables ( excep(~'
tomatoes/eggplants, and peppers);'
whole grains, and nuts.

Studies are very limited and
inconsistent. Some general
suggestions can be suggested for
·healthy lifestyle. Alcohol
·consumption worsens symptorns.

A corrected gene is being inserted
into the skin cell and replaces
genetic material by mitosis.
Insertion via micro-needles and
electric bean1.

Experimental studies performed
on mice. Not sate as there is no
studied bng tenn or adverse
eflects. No human trial has been
performed.

1

A new specific protein has been
. singled out in 2012. The protein
located on gene REG3A has
shown a strong correlation to
psoriasis and has ·a potential to
·become a new target for evolving
treatments•.
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No studies have been performed
for such treatment. The discovery
lays a ground for the future
explorations.

Special Demographics: Children and Adolescents
It is important for nurses to understand that direct involvement in child's care has

its impact on quality on family dynamics. Those families usually have restricted
social activities or cancelled trips due to scheduled or long term treatments.
Depression, frustration, emotional stress, concerns, anxiety due to lack of control
over child's disease and knowledge of its lifelong effect are very common in those
families. Financial burden because of treatment expenses also should be considered
as many of the treatments are expensive.
Family assessment is as important as the child carrying this condition. Carefully
listen to the child's and parents' concerns. School and society in general present a
great potential for increased peer pressure, bullying, and rejection due to
expressive features of psoriasis. Kids feel ashamed, stared at, and marked as
contagious. Such a state is a risk factor for developing early signs of depression.
A successful assessment will find the information about current treatment,
difficulties in treatment (side effects, schedule, costs), presence of social pressure
(such as teasing, bullying, staring), body image status, access to information and
services, emotional status for depression or suicidal ideations, and active
participation in a support group or counseling. It is also important to reinforce the
education regarding the treatments, especially these with severe side effects, and
continue monitoring physiological and psychological status.

Friends: body
image

.
Treatment: side
, effects ,

Family: grief and
;struggle
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Special Demographics: Pregnant Women
As any other chronic disease, psoriasis in pregnancy presents certain risks for
negative outcomes. Certain complication related to the course of the disease are
being detected and reported. There is also a strong evidence for the positive impact
of pregnancy on psoriasis. Below is a summary of potential outcomes and proper
handling of those cases. Generally, psoriasis is not considered a serious threatening
condition to a future mother by the healthcare personnel and tllis information can
be easily overlooked. Importance of asking the patient relevant questions is
unquestionable. Education about those risks is equally important.

Psoriatic, Flares

~qhronic

Hypertension

General improvement of the skin condition from 10 to 20
weeks of pregnancy due to high maternal blood estrogen.
However, about 90% of the patients will develop flares within<
6 weeks postpartum.
Educate the patient regarding expected worsening of the
symptoms.
Consistent evidence that pregnant women with psoriasis are
more likely to develop chronic hypertension. Blood pressure
screening and potential management are vital as hypertension,
can lead to severe complications including fatal outcome.

R,ecurring'
Spontaneous ·
Abortions,

As with hypertensions, psoriasis puts pregnant women at
higher risk for spontaneous abortions. Obtain history of
previous pregnancies in order to detennine thisrisk.

Cesarean Section

Psoriasis presents as an independent risk factor for .caesarian
delivery.

Psoriasis Management First line: topical corticosteroids and emollients
Avoid: coal tar and vitamin D-like substances. Not enough
evidence for their safety
Second line: UVB.
Must be avoided due to teratogenicity: oral and topical
retinoids (related to vitamin A), methotrexate,'calcipotriol
derivatives.
Biological agents did not show tetragenicity but their effect on
pregnancy is unknown. Take precaution dirring severe
psoriasis flares.
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Special Demographics: Surgical and Acute Patients
There is a split of opinion between dermatologists and surgical specialists regarding
operational incisions on patients with active psoriasis. Dermatologists in general do
not see any contraindications for cutting psoriasis covered skin. Sergeants, on the
other hand, tend to oppose such practices due to increased risk of infections. The
tendency is to treat active psoriasis before the elective procedure. There is very
limited research in this area and the table below summarizes some possible known
scenarios on acutely ill patients with comorbid psoriasis.

Surgery on active
psoriatic skin

Psoriasis treatment initiation prior to a surgery isrecommended to
avoid infection complications.
If the surgery is urgent increased dose antibiotics and
corticosteroid therapy immediately after surgery is anticipated.
Usually sergeants will notperform an incision longer than 30cm
on psoriatic skin. However, ther'( is evidence that such incisions
do not necessarily cause further complications.

---~--~-~-----~--~~~---~--~~~~~--~~--

;Post-Surgical
fPatients with_
Nosocomial
--Infections
-

The skin with psoriasis is a favorable environment for
opportunistic microorganisms.
Use of silver induced dressing showed a significant improvement
up until complete healing of postsurgical wounds complications.
One case study presented a complication on a patient with
psoriasis whq underwent an orthopedic surgery and acquired
methicillin resistant Staphylococcus aureus (MRSA). The client
was completely cleared with silver covered dressing after many
mollths of unsuccessful antibiotic treatment and traditional
dressing.

lmmunocompromised Treatment with biologic and systemic agents, especially with
_patients and patients - mycophenolate is highly recommended.
Study shows that patients with weakened immune system such as
with HIV
--organ transplant patients and human immunodeficiency'virus
(HIV) infected clients show positive results with-use ofthis
- treatment.

f~~-----~~~~~~,--~~~~-----------~~~--~~~~

Koebner•
-(isomorphic)
phenomenon
-

New pathological lesions development at the site of surgical
procedures or other traumas on clear skin in patients with
psoriasis or other cutaneous conditions. A response to
mechanical or thermal trauma, dermatoses, allergic reactions,
therapies like iodine application or ultraviolet light and' other
interventions.
_
_
Pay close attention to new formation in postoperative/traumatic
patients.
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Psychological Aspect
Distorted body image: most of the psoriasis patients feel unclean and messy due
to constant flaking of the skin. This adds to reduction of quality of everyday life.
Many patients also feel that they are being stared at by strangers.
Shame and uncertainty: The vast majority of the psoriasis clients make efforts to
cover psoriasis expression to avoid an unwanted attention to their condition. In
some cases they cover and hide it from their families, spouses or even physician.
Asking appropriate questions and expressing non-judgmental attitude is key.
Stigmatization and bullying: Most of the patients are convinced that general
public sees psoriasis as a contagious disease. It is more prominent in teenagers and
younger adults who are subjected to unrealistic body image standard promoted by
the media and society. Bullying increases chances for distorted body image and
personal unworthiness. The severity ofthe symptoms correlated to the low selfesteem, and lower quality of life, especially in women. Pay close attention to the
patient's needs and discuss psychological status as a part of assessment.
Relationship management: Severe psoriasis symptoms become a challenge or
even an obstacle in relationship for both men and women suffering from psmiasis.
Some of them even go through rejection due to their appearance. Studies show that
patients with psoriasis are more fearful to engage in sexual relationships due to
distorted self-image.
Stress: About half of psoriasis patients experience increased stress level due to
exacerbation episodes. Such a reaction would trigger even more severe psoriatic
response causing even more stress. It is important to recognize if this vicious circle
exists in your patient's life.
Harmful lifestyles! It is also found that many psDriasis patients are likely to
engage in self-destructive behaviors like binge eating, substance abuse and
unprotected sexual contact. There is a correlation between personal belief in
symptom management and treatment and harmful behavior. Addressing those
issues during the formal assessment is an important step for improving quality of
life.
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Lifestyle Alterations
Symptom management: Follow the treatment regimen closely. Use emollients for itch
control; manage a diary of the flare outbreaks to find a pattern and triggers.

Avoidance of known triggers: Prevent streptococcal infections, avoid severe stress.
Infection control: Avoid large crowds, especially during infectious outbreaks, hand
hygiene, inspect flared sites for signs of infections, seek immediate attention if new lesions or
suspicious formations appear. Be especially vigilant after invasive medical procedures.

Healthy lifestyle: Smoking cessation, limited alcohol consumption, balanced diet, active
lifestyle and hydration are highly encouraged. Avoid synthetic tight clothing or wool- they can
cause itch. Reduce consumption of foods with inflanunatory properties like animal protein and
fat.

Stress reduction: Use relaxation techniques like meditation, deep breathing, muscle
relaxation, guided imagery, and counseling. Develop coping plan with your therapist. Utilize
local or online support groups.

Self-perception: Think positive. Wear comfortable, loose-fitting clothes. Avoid dark
colors as they make skin flakes too visible. Carry emollients with you. Do not avoid sun: the sun
is an excellent source for UVB which is beneficial for psoriasis management. Tight clothes also
can cause excessive sweating, which alleviates symptoms. Do not be afraid of talking about your
condition; people are more likely to understand if you are open about it.

Managing relationships: Discuss your fears, concerns, and experience with your family
and friends. Try to be as clear as possible about your experience in order for them to understand
your frustration. Do not blame them but rather let them participate in your routine. Do not limit
social interaction.

Adjustment to social interaction: Create a support circle. Be open with your
management about your condition and request accommodations if needed. Be organized with
your doctor appointments; discuss the issue with management to find appropriate arrangements.

Up to date education: Keep up with the most recent findings and researches. Do not skip
doctor appointments. Subscribe to newsletter services from National Psoriasis Foundation or
other organizations. Drug companies producing psoriasis medications also have access to most
recent updates on condition's fmdings.

12

Resources
Resources for nursing education:
Agency for Healthcare Research and Quality (AHRQ):
http://www.guideline.gov/content.aspx?id=38575&search=psoriasis
Medline Plus: http://www.nlm.nih.gov/medlineplus/psoriasis.html
PAS! assessment tool: http://www. pasitraining.com/calculator/step_1. php

Resources for patients and their families:
International Federation ofPsoriasis Associations (IFPA): http://www.ifpapso.org/
National Psoriasis Foundation: www.psoriasis.org
Place for !.:ids with psoriasis: www.PsoMe.org
Psoriasis Cure Now: http://www.psoriasis-cure-now.org/
Psoriasis ~'Jeaks: http://www.psoriasis.com/?cid=ppc_ppd_ hderm_ggl_041021
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